Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Biolase Technology Inc.

BioPhotonics
Sep 2011
Dental laser manufacturer Biolase Technology Inc. of Irvine, Calif., has received two more patents from the US Patent and Trademark Office for its laser technologies that treat various eye conditions, including presbyopia – the decline of near vision in midlife. The patents are the seventh and eighth to be issued under the “Methods for Treating Eye Conditions” patent family. US Patent number 7,967,017 includes 29 claims and introduces a strategy for identifying optimal treatment zones for the reversal of presbyopia. US Patent No. 7,909,040 includes 10 claims and relates to the shape of the treatment laser beam and specific ablative patterns for treating the condition.


GLOSSARY
presbyopia
A state in which the human eye has very little or no power of accommodation. A common and normal condition in the eyes of those age 50 and older.
Americasbiolase technologyBiophotonicsBusinessCaliforniadental laserslaser ablative patternslaser beamsMethods for Treating Eye Conditionsnear-vision losspatent number 7909040patent number 7967017presbyopiaRapidScanUS Patent and Trademark Officelasers

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.